Autolus Therapeutics PLC (AUTL)

2.29 +0.05 (+2.23%) USD  |  NASDAQ  |  Dec 20, 16:00
2.285 0.00 (0.00%) After-Hours: 20:00
More

Autolus Therapeutics Max Drawdown (5Y): 96.58% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
TC BioPharm (Holdings) PLC --
Adaptimmune Therapeutics PLC 96.45%
Biodexa Pharmaceuticals PLC 100.00%
Bicycle Therapeutics PLC 78.82%
DBV Technologies SA 98.19%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -54.94
Beta (5Y) 1.984
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 86.43%
Historical Sharpe Ratio (5Y) -0.3291
Historical Sortino (5Y) -0.7731
Monthly Value at Risk (VaR) 5% (5Y Lookback) 31.12%